GURUFOCUS.COM » STOCK LIST » USA » NYSE » Johnson & Johnson (NYSE:JNJ) » Definitions » Shiller PE Ratio
Switch to:

Johnson & Johnson Shiller PE Ratio

: 27.72 (As of Today)
View and export this data going back to 1944. Start your Free Trial

As of today (2022-08-10), Johnson & Johnson's current share price is $170.18. Johnson & Johnson's E10 for the quarter that ended in Jun. 2022 was $6.14. Johnson & Johnson's Shiller PE Ratio for today is 27.72.

The historical rank and industry rank for Johnson & Johnson's Shiller PE Ratio or its related term are showing as below:

JNJ' s Shiller PE Ratio Range Over the Past 10 Years
Min: 15.56   Med: 24.6   Max: 33.32
Current: 27.75

During the past years, Johnson & Johnson's highest Shiller PE Ratio was 33.32. The lowest was 15.56. And the median was 24.60.

JNJ's Shiller PE Ratio is ranked worse than
56.16% of 495 companies
in the Drug Manufacturers industry
Industry Median: 24.41 vs JNJ: 27.75

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Johnson & Johnson's adjusted earnings per share data for the three months ended in Jun. 2022 was $1.800. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $6.14 for the trailing ten years ended in Jun. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation


Johnson & Johnson Shiller PE Ratio Historical Data

The historical data trend for Johnson & Johnson's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.82 26.86 29.45 31.45 29.88

Johnson & Johnson Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.39 29.52 29.88 29.93 28.93

Competitive Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Johnson & Johnson Shiller PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Shiller PE Ratio falls into.



Johnson & Johnson Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Johnson & Johnson's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=170.18/6.14
=27.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson's E10 for the quarter that ended in Jun. 2022 is calculated as:

For example, Johnson & Johnson's adjusted earnings per share data for the three months ended in Jun. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2022 (Change)*Current CPI (Jun. 2022)
=1.8/123.3228*123.3228
=1.800

Current CPI (Jun. 2022) = 123.3228.

Johnson & Johnson Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201209 1.050 97.633 1.326
201212 0.910 96.871 1.158
201303 1.220 98.209 1.532
201306 1.330 98.518 1.665
201309 1.040 98.790 1.298
201312 1.230 98.326 1.543
201403 1.640 99.695 2.029
201406 1.510 100.560 1.852
201409 1.660 100.428 2.038
201412 0.890 99.070 1.108
201503 1.530 99.621 1.894
201506 1.610 100.684 1.972
201509 1.200 100.392 1.474
201512 1.150 99.792 1.421
201603 1.590 100.470 1.952
201606 1.430 101.688 1.734
201609 1.530 101.861 1.852
201612 1.380 101.863 1.671
201703 1.610 102.862 1.930
201706 1.400 103.349 1.671
201709 1.370 104.136 1.622
201712 -3.990 104.011 -4.731
201803 1.600 105.290 1.874
201806 1.450 106.317 1.682
201809 1.440 106.507 1.667
201812 1.120 105.998 1.303
201903 1.390 107.251 1.598
201906 2.080 108.070 2.374
201909 0.660 108.329 0.751
201912 1.500 108.420 1.706
202003 2.170 108.902 2.457
202006 1.360 108.767 1.542
202009 1.330 109.815 1.494
202012 0.650 109.897 0.729
202103 2.320 111.754 2.560
202106 2.350 114.631 2.528
202109 1.370 115.734 1.460
202112 1.770 117.630 1.856
202203 1.930 121.301 1.962
202206 1.800 123.323 1.800

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Johnson & Johnson  (NYSE:JNJ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Johnson & Johnson Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Johnson & Johnson logo
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States.
Executives
Adamczyk Darius director 855 S. MINT STREET CHARLOTTE NC 28202
Hait William officer: See Remarks ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Mammen Mathai officer: EVP, Pharm, R&D THERAVANCE,INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Broadhurst Vanessa officer: EVP, Global Corp Aff. ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Swanson James D. officer: EVP, Chief Information Officer ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
West Nadja director 1915 REXFORD ROAD CHARLOTTE NC 28211
Decker Robert J officer: Controller, CAO ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Joly Hubert director C/O BEST BUY CO, INC. 7601 PENN AVENUE SOUTH RICHFIELD MN 55423
Weinberger Mark A director METLIFE, INC. 200 PARK AVENUE NEW YORK NY 10166
Hewson Marillyn A director C/O CARPENTER TECHNOLOGY CORPORATION PO BOX 14662 READING PA 19612-4662
Mongon Thibaut officer: Exec VP, WW Chair, Consumer JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Wengel Kathryn E officer: EVP, Chief GSC Officer JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Wolk Joseph J officer: Exec VP, CFO JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Mcevoy Ashley officer: EVP, WW Chair, Medical Devices JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Taubert Jennifer L officer: EVP, WW Chair, Pharmaceuticals JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933

Johnson & Johnson Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)